A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Bioequivalence Study of Sorafenib Tablet and Nexavar
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- WITHDRAWN
- Phase
- PHASE2
An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
- Status
- COMPLETED
- Phase
- PHASE3
Trial of TRC105 and Sorafenib in Patients With HCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
- Status
- UNKNOWN
- Phase
- NA
Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- NA
Adjuvant Therapies for Patients With HCC and MVI
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
- Status
- UNKNOWN
- Phase
- PHASE1
Epigenetic Reprogramming in Relapse AML
- Status
- TERMINATED
- Phase
- PHASE1